Total Funding
8
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Iontera specializes in the design and development of intelligent transdermal drug delivery.
- Chris Hobson: President & CEOPast Role: Jana, Chief Operating Officer
About the Company
Iontera is pioneering in the design and development of intelligent transdermal drug delivery (TDD). TDD has long held the promise of non-invasive drug delivery, adding convenience, reduced costs, and improved patient compliance via the application of a patch to the skin. The missing components in TDD have been controlled release of the drug carried
in the patch and the breadth of drugs that can actually be transferred through the skin. Iontera’s patented IonIQ technology intelligently enhances and controls delivery via a single-electrode design that is governed by a programmable onboard computer.
